Peter Mazzone, MD

Peter Mazzone, MD, MPH, is Staff and Director of the Lung Cancer Program and Lung Cancer Screening Program for the Respiratory Institute.

Dr. Mazzone is board-certified in internal medicine, pulmonary medicine and critical care medicine.

Treatment interests include lung nodules, lung cancer and intensive care unit medicine. Research interests include cancer biomarker development (breath analysis, blood and urine testing), lung cancer diagnostics, lung nodule evaluation, lung physiology assessment and lung cancer screening.

Education & Professional Highlights

Appointed: 2001

Education & Fellowships

Graduate School - Northeastern Ohio Univ College of Medicine
MPH
Rootstown, OH USA
2001

Fellowship - Cleveland Clinic
Pulmonary & Critical Care Medicine
Cleveland, OH USA
2001

Residency - Cleveland Clinic
Internal Medicine
Cleveland, OH USA
1998

Internship - Cleveland Clinic
Internal Medicine
Cleveland, OH USA
1995

Medical Education - University of Western Ontario Schulich School of Medicine & Dentistry
MD
London, ON Canada
1994

Undergraduate - University of Western Ontario
London, Ontario,
1990

Professional Highlights

• Former Chair, Thoracic Oncology Network of the American College of Chest Physicians.
• Chair, Planning Committee, Thoracic Oncology Assembly of the American Thoracic Society.
• Cancer Biomarkers Study Section, NIH.
• Member of Executive Committee Lung Cancer Living Guidelines for the American College of Chest Physicians. Lead of Lung Cancer Screening Guideline.
• Member of Committees for Implementation of Lung Cancer Screening, American College of Chest Physicians and American Thoracic Society.
• American Lung Association - National Lung Cancer Expert Medical Advisory Panel.
• Chest 2016 - Program Vice-Chair, Chest 2017 - Program Chair
• American Cancer Society Lung Cancer Screening Roundtable

Certifications

• Internal Medicine

Specialty Interests

Acute respiratory distress syndrome(ARDS), lung cancer, lung nodules, sepsis Acute respiratory distress syndrome(ARDS), asthma, lung cancer, lung nodules, lung cancer screening, pneumonia, sepsis

Awards & Honors

• Best Doctors in America, 2004-2016
• Guide to America's Top Physicians, 2004-2016
• Cleveland's Best Doctors, 2006-2016
• Best Doctors, Northern Ohio Live magazine, 2007-2008

Innovations & Patents

• The development of a breath test (volatile metabolites) for the identification of lung cancer (research in progress).
• The development of a urine test (volatile metabolites) for the identification of lung cancer (research in progress).
• The development of a blood test (non-volatile small molecule metabolites) for the identification of lung cancer (research in progress).

Memberships

• American Thoracic Society
• American College of Chest Physicians
• International Association for the Study of Lung Cancer